KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Dividends Paid - Common (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Dividends Paid - Common for 13 consecutive years, with $149.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Dividends Paid - Common rose 9.56% year-over-year to $149.0 million, compared with a TTM value of $583.0 million through Dec 2024, up 11.47%, and an annual FY2025 reading of $636.0 million, up 9.09% over the prior year.
  • Dividends Paid - Common was $149.0 million for Q4 2024 at Thermo Fisher Scientific, down from $150.0 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $150.0 million in Q3 2024 and bottomed at $76.0 million in Q1 2020.
  • Average Dividends Paid - Common over 5 years is $114.6 million, with a median of $117.0 million recorded in 2022.
  • The sharpest move saw Dividends Paid - Common grew 18.39% in 2021, then grew 9.56% in 2024.
  • Year by year, Dividends Paid - Common stood at $87.0 million in 2020, then increased by 18.39% to $103.0 million in 2021, then grew by 13.59% to $117.0 million in 2022, then increased by 16.24% to $136.0 million in 2023, then increased by 9.56% to $149.0 million in 2024.
  • Business Quant data shows Dividends Paid - Common for TMO at $149.0 million in Q4 2024, $150.0 million in Q3 2024, and $149.0 million in Q2 2024.